Physician Wealth Advisors’s Ambev ABEV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$4.93K Buy
1,687
+497
+42% +$1.48K ﹤0.01% 1143
2026
Q2
$3.74K Buy
1,190
+160
+16% +$500 ﹤0.01% 1224
2026
Q1
$3.01K Hold
1,030
– – ﹤0.01% 1180
2025
Q4
$2.54K Hold
1,030
– – ﹤0.01% 1186
2025
Q3
$2.3K Sell
1,030
-392
-28% -$897 ﹤0.01% 1161
2025
Q2
$3.43K Buy
1,422
+392
+38% +$954 ﹤0.01% 893
2025
Q1
$2.4K Sell
1,030
-2,321
-69% -$4.64K ﹤0.01% 838
2024
Q4
$6.2K Buy
+3,351
New +$7.41K ﹤0.01% 699
2020
Q1
– Sell
-12,574
Closed -$58K – 109
2019
Q4
$58K Buy
12,574
+494
+4% +$2.19K 0.03% 120
2019
Q3
$52K Buy
+12,080
New +$57.9K 0.03% 107

Other funds holding ABEV

Physician Wealth Advisors's ABEV Position: Q3 2026 in Review

Physician Wealth Advisors increased its Ambev (ABEV) stake by 42% in Q3 2026, buying an estimated $1.48K and bringing the position to 1,687 shares worth $4.93K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Physician Wealth Advisors first reported a position in ABEV in Q3 2019 and has held it in 10 quarters since. The position peaked at $58K in Q4 2019. 396 funds tracked by Wall St. Rank hold ABEV as of Q3 2026.

  • Physician Wealth Advisors held 1,687 shares of Ambev worth $4.93K as of Q3 2026.
  • Physician Wealth Advisors bought 497 Ambev shares in Q3 2026, an estimated $1.48K.
  • Ambev made up ﹤0.01% of Physician Wealth Advisors's portfolio in Q3 2026, its #1143 holding.
  • Physician Wealth Advisors first reported a position in Ambev in Q3 2019 and has held it in 10 quarters since.
  • Physician Wealth Advisors's Ambev position peaked at $58K in Q4 2019.
  • 396 funds tracked by Wall St. Rank held Ambev as of Q3 2026.

Based on Physician Wealth Advisors's 13F filing for Q3 2026, filed 20 Oct 2026.